Fabry disease in children: agalsidase-beta enzyme replacement therapy.
about
Paediatric Fabry diseaseRecommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document.Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies.Pain in Fabry Disease: Practical Recommendations for Diagnosis and Treatment.Genetic Screening of Mutations Associated with Fabry Disease in a Nationwide Cohort of Juvenile Idiopathic Arthritis Patients.Chronic intestinal pseudo-obstruction. Did you search for lysosomal storage diseases?Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages.Cornea verticillata supports a diagnosis of Fabry disease in non-classical phenotypes: results from the Dutch cohort and a systematic review.Auditing the frequency and the clinical and economic impact of testing for Fabry disease in patients under the age of 70 with a stroke admitted to Saint Vincent's University Hospital over a 6-month period.Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study.Diagnostic dilemma and delay in Fabry disease: insights from a case series of young female patients.
P2860
Q26770283-3EEC3300-89B6-43C2-A74A-DB6BBAB4393EQ35247511-C267C008-8049-4E4E-8C17-3500BC33E757Q35587768-566E6D08-8647-4B05-B436-626C60126A77Q36309032-216D2452-2AB2-49FA-B63A-3A131097A244Q37352268-D9D36083-A6FD-460D-AEAD-456E332B422BQ37672375-78E3503B-39C6-4781-B3B3-2A8FD9E80A04Q37725235-B0B4868C-0E06-4D64-9793-9ABA3ECD318BQ38184922-B50C9223-9F94-439F-A4C6-FF61209CE3C0Q38354004-8E29F92B-43B0-4865-B01A-FC22162D696EQ38687892-2860B775-E218-4BDD-BE41-8CC2AF8907F9Q39097273-3D63104A-53EE-4F98-BA4C-5FABD716A127Q47818876-7FC54636-829B-43B4-8FAB-6C2FD3745682
P2860
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@en
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@nl
type
label
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@en
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@nl
prefLabel
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@en
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@nl
P2093
P2860
P1433
P1476
Fabry disease in children: agalsidase-beta enzyme replacement therapy.
@en
P2093
A K Rasmussen
A Meldgaard Lund
L Borgwardt
U Feldt-Rasmussen
P2860
P304
P356
10.1111/J.1399-0004.2012.01947.X
P577
2012-09-27T00:00:00Z